Results 31 to 40 of about 984,362 (340)

Comparative study of pressure (ankle-brachial pressure index) and flow (strain gauge plethysmography and reactive hyperaemia) measurements in diagnosis of peripheral arterial disease in patients with severe aortic stenosis.

open access: yesPLoS ONE, 2019
BackgroundThe measurement of the ankle-brachial pressure index is a straightforward method for the detection of peripheral disease in the lower limbs. Only a few old studies with small numbers of patients have been conducted comparing the gold standard ...
Nadjib Schahab   +7 more
doaj   +1 more source

Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease

open access: yesClinics, 2011
OBJECTIVE: To determine whether there is an association between serum ischemia-modified albumin and the risk factor profile in type 2 diabetic patients with peripheral arterial disease and to identify the risk markers for peripheral arterial disease ...
Shao-Gang Ma   +3 more
doaj   +1 more source

Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease [PDF]

open access: yes, 2018
BackgroundPeripheral arterial disease (PAD) has a significant negative impact on the quality of life of individuals. Understanding the experiences of people living with PAD will be useful in developing comprehensive patient-centred secondary prevention ...
Abaraogu, Ukachukwu Okoroafor   +3 more
core   +2 more sources

Borderline peripheral arterial disease [PDF]

open access: yesInternational Journal of Angiology, 2008
Peripheral arterial disease (PAD), along with coronary artery disease and cerebrovascular disease, is a manifestation of systemic atherosclerosis. These cardiovascular diseases (CVDs) are the leading cause of death in the world, representing 30% of all global deaths.
Päivi, Korhonen, Pertti, Aarnio
openaire   +2 more sources

Antithrombotic therapy in peripheral arterial disease

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundPatients with peripheral arterial disease (PAD) are at increased risk for major adverse cardiovascular events (MACE) such as cardiovascular death, myocardial infarction, and stroke as well as major adverse limb events (MALE) such as amputation ...
Christine Espinola-Klein   +5 more
doaj   +1 more source

Preventive Therapies in Peripheral Arterial Disease

open access: yesBiomedicines, 2023
Atherosclerosis, while initially deemed a bland proliferative process, is now recognized as a multifactorial-lipoprotein-mediated inflammation-driven pathway.
Aangi J. Shah   +2 more
doaj   +1 more source

Predictors of walking capacity in peripheral arterial disease patients [PDF]

open access: yes, 2013
OBJECTIVE: To estimate walking capacity in intermittent claudication patients through a prediction model based on clinical characteristics and the walking impairment questionnaire. METHODS: The sample included 133 intermittent claudication patients of
Chehuen, MR   +7 more
core   +2 more sources

Prevalence of peripheral arterial disease and related risk factors in Turkish elders

open access: yesBMC Family Practice, 2011
Background It is known that prevalence of peripheral arterial disease being a widespread atherosclerotic vascular disease increases by age. On the other hand, no comprehensive study showing the prevalence of peripheral arterial disease in Turkish elders ...
Yesilkayali Teoman   +3 more
doaj   +1 more source

Diabetic foot disease and oedema [PDF]

open access: yes, 2013
Diabetic foot ulcers (DFUs) are common and disabling, giving rise to significant morbidity and mortality as well as worldwide socioeconomic problems. Despite treatment, DFUs readily become chronic wounds and may lead to major lower limb amputations.
Ho, TK, Leigh, RD, Tsui, J
core   +1 more source

Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]

open access: yes, 2010
Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy